FLUDARABINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fludarabine, and when can generic versions of Fludarabine launch?
Fludarabine is a drug marketed by Actavis Llc, Actavis Totowa, Areva Pharms, Caplin One Labs, Extrovis, Fresenius Kabi Usa, Hikma, Hospira, Rising, and Sagent Pharms Inc. and is included in eleven NDAs.
The generic ingredient in FLUDARABINE is fludarabine phosphate. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fludarabine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fludarabine
A generic version of FLUDARABINE was approved as fludarabine phosphate by HIKMA on August 28th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FLUDARABINE?
- What are the global sales for FLUDARABINE?
- What is Average Wholesale Price for FLUDARABINE?
Summary for FLUDARABINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for FLUDARABINE |
| DailyMed Link: | FLUDARABINE at DailyMed |


